查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197167

中空纖維過濾市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Hollow Fiber Filtration Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內 (2022-2027)，中空纖維過濾市場預計將以 14.1% 的複合年增長率註冊。

在 COVID-19 階段，由於人口中傳染病病例的增加，預計中空纖維過濾市場將增長。 對 COVID-19 疫苗和療法的需求不斷增加正在推動中空纖維過濾市場的增長。 根據 Computational and Structural Biotechnology Journal 2021 年 5 月發表的一篇題為“當前 COVID-19 疫苗平台概述”的文章，有 184 種候選疫苗處於臨床前測試階段，88 種處於臨床階段。據說它曾是 中空纖維過濾是回收 COVID-19 候選疫苗的重要下游工藝，因為它有利於高選擇性和有效的候選疫苗。 因此，預計 COVID-19 將在整個大流行期間增加對中空纖維過濾技術的需求。

生物製藥行業研發投資的增加是推動市場增長的主要因素之一。 對生物製藥的需求不斷增長，加上質量標準不斷提高以滿足市場參與者的監管要求，預計將對市場增長產生積極影響。 根據美國國會預算辦公室2020年發布的一份報告，生物製藥行業在研發活動上的支出約為830億美元。 此外，2021 年 7 月，世界衛生組織 (WHO) 加速器從各國政府籌集了 120 億美元的疫苗資金，其中包括 17 億美元的研發支持。 生物製藥領域研發投入的增加有望推動中空纖維膜過濾市場的增長。

此外，由於過濾是標准單元操作中必不可少的步驟，因此全球批准的生物製藥數量不斷增加以及生物製藥產量的增加正在推動對中空纖維過濾市場的需求。 2020 年，美國食品和藥物管理局 (FDA) 平均每年批准 53 種新藥。 這種研發活動的增加，加上生物製藥產品批准的增加，預計將推動市場增長。

因此，由於上述因素，市場有望在預測期內出現增長。 然而，政府對藥品安全的嚴格監管可能會阻礙市場增長。

中空纖維過濾市場趨勢

在中空纖維過濾市場，製藥和生物技術行業預計將佔據主要市場份額。

由於在生產過程中廣泛使用中空纖維過濾，預計製藥和生物技術行業將成為最賺錢的行業。 製造過程中超濾、滲濾和微濾工藝對中空纖維的需求不斷增長，以及製藥和生物技術領域對連續製造技術的使用不斷增加，預計將推動市場增長。

中空纖維過濾的使用降低了與復雜的下游工藝相關的成本，從而提高了生產率並有助於遵守良好生產規範 (GMP) 和食品藥品監督管理局 (FDA) 的過濾指南。 由於中空纖維過濾在產品分離和純化中的廣泛應用，製藥和生物製藥行業研發活動投資的增加將直接影響對中空纖維過濾的需求。 例如，2022 年 4 月，輝凌製藥在海得拉巴開設了一個綜合研發和製造設施，總投資為 3000 萬歐元。 研發能力包括配方開發、包裝開發和分析開發。 製藥行業的這種增長導致越來越多地使用中空纖維膜進行產品過濾，從而促進了該行業的增長。

因此，由於上述因素，預計製藥和生物技術行業板塊在預測期內將會增長。

北美將佔據很大的市場份額，預計在預測期內也會如此

由於該地區生物製藥領域研發活動的增加，預計美國地區的中空纖維過濾市場將會增長。 根據 Binder Dijker Otte (BDO) USA Reports，生物技術指數 (NBI) 上市公司的收入在 2020 年增長了 10.49 億日元。 2020年，美國製藥行業平均研發支出增長16%，達到2.8425億美元。 如此一來，加上美國地區對生物類似藥產品的需求增加，研發活動活躍，其在治療藥物下游工藝中的廣泛應用，有利於中空纖維過濾市場的增長，我們提供了機會。 例如，2020 年 3 月，Thermo Fisher Scientific 投資約 4.75 億美元，用於擴大其生物製劑、細胞和基因治療以及藥物開發設施，並提高其全球商業能力。 同樣，2020 年 1 月，禮來公司簽訂了收購生物製藥公司 Dermira 的協議。

此外，由於主要市場參與者的存在和產品開發的先進技術，預計該地區將佔據最大份額。 此外，不斷增加的研發活動和有利的醫療保健基礎設施的存在極大地推動了該地區的市場增長。

中空纖維過濾市場競爭者分析

中空纖維過濾市場競爭激烈，由幾家大型企業組成。 從市場份額的角度來看，一些主要參與者目前主導著市場。 目前主導市場的一些公司是 Repligen Corporation、Sartorius、Danaher Corporation、Asahi Kasei Medical、Parker Hannifin Corp、Mar cor、Koch Separation solutions、Meissner Filtration Products, Inc、Antilia Scientific 和 Biotree。

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 增加對生物製藥研發的投資
    • 越來越喜歡連續製造
  • 市場製約因素
    • 關於藥物安全的嚴格政府法規
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分

  • 按材料
    • 高分子材料
    • 陶瓷
  • 按技術
    • 微濾
    • 超濾
  • 最終用戶
    • 製藥和生物技術行業
    • 研究所
    • 委託研究機構
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Repligen Corporation
    • Sartorius
    • Danaher Corporation
    • Asahi Kasei Medical Co., Ltd
    • Parker Hannifin Corp
    • Mar cor
    • Koch Seperation solutions
    • Meissner Filtration Products, Inc
    • Antylia Scientific
    • Biotree

第7章 市場機會今後動向

簡介目錄
Product Code: 90456

The Hollow Fiber Filtration Market is projected to register a CAGR of 14.1% during the forecast period (2022-2027).

Amid COVID-19 phase, the hollow fiber filtration market is expected to grow owing to the rising cases of infectious diseases among the population. An increase in the demand for vaccines and treatment drugs for COVID-19 is a driving factor for the growth of the hollow fiber filtration market. According to the article titled "An overview of current COVID-19 vaccine platforms" published by the Computational and Structural Biotechnology Journal in May 2021, there were 184 vaccine candidates in preclinical testing and another 88 vaccine candidates in clinical phases. The hollow fiber filtration method is a crucial process in the downstream process for the recovery of the COVID-19 vaccine candidates as the hollow fiber filtration favors high selectivity and effective vaccine candidates. Hence, COVID-19 is assumed to increase the demand for the hollow fiber filtration techniques throughout the pandemic phase.

The increasing investment in the research and development of the biopharmaceutical industry is one of the major factors driving the market's growth. The growing demand for biopharmaceutical drugs coupled with the continuous improvement of quality standards to meet the regulatory requirements by the market players is expected to have a positive impact on the growth of the market. The report published by the Congressional Budget Office in 2020 stated that the biopharmaceutical industry spent around 83 billion USD on research and developmental activities. Additionally, in July 2021, the World Health Organization (WHO) accelerator raised 12 billion USD in funding for the vaccines from various governments, including USD 1.7 billion for research and development support. Such an increase in the investment in the research and development of the biopharmaceutical sector is expected to boost the growth of the hollow fiber filtration market.

Furthermore, an increase in the number of approved biopharma products worldwide and increasing manufacturing of biopharmaceutical drugs is expected to increase the demand for the hollow fiber filtration market as filtration is an essential step in the standard unit operation. In 2020, the United States Food and Drug Administration (FDA) approved an average of 53 new medicines annually. Such an increase in research and developmental activities coupled with the increasing product approvals of biopharmaceuticals is expected to drive the market's growth.

Thus, owing to the abovementioned factors, the market is expected to project growth over the forecast period. However, strict government regulations related to drug safety may hinder the growth of the market.

Hollow Fiber Filtration Market Trends

The Pharmaceuticals and Biotechnology Industries Segment is Expected to Hold a Major Market Share in the Hollow Fiber Filtration Market Market.

The pharmaceutical and biotechnology industries are expected to be the most lucrative segment, with extensive usage of hollow fiber filtration in their production processes. The expanding demand for hollow fibers in ultrafiltration, diafiltration, and microfiltration processes in the manufacturing process and the increased usage of continuous manufacturing techniques in the pharma and biotech sectors is expected to propel the growth of the market.

The usage of hollow fiber filtration helps decrease the costs associated with the complicated downstream processing, thereby increasing productivity and helping in the adherence to Good Manufacturing Process (GMP) and Food and Drug Administration (FDA) guidelines for filtration. The growth in investement for research and development activities of the pharmaceutical and biopharmaceutical industries directly impacts the demand for hollow fiber filtration owing to the extensive usage for isolation and purification of the products. For instance, in April 2022, Ferring Pharmaceuticals opened its integrated R&D and manufacturing facility in Hyderabad, which was established with a total investment of EUR 30 million. The R&D capability includes formulation development, packaging development, and analytical development. This increase in the growth of the pharmaceutical sector facilitates the increasing usage of hollow fiber filtration for filtration of products, thereby propelling the growth of the segment.

Thus, owing to the abovementioned factors, the pharmaceutical and biotechnology industries segment is expected to grow over the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period.

The hollow fiber filtration market is expected to grow in this region owing to the increase in research and development activities in the biopharma sector in the United States region. According to the Binder Dijker Otte (BDO) USA Reports, in 2020, companies listed on the biotechnology index (NBI) saw a growth in revenue of 1.049 billion. In 2020, average research and development spending increased by 16% to 284.25 million USD in the United States pharmaceutical industry. Thus, the increasing research and development activities, coupled with the increasing demand for biosimilar products in the United States region, provide lucrative opportunities for the growth of the hollow fiber filtration market as they are extensively used for the downstream process of therapeutics. For instance, in March 2020, Thermo Fisher Scientific Inc. invested nearly USD 475 million to expand its biologics, cell and gene therapy, and drug product development facilities and increase its global commercial capabilities. Similarly, in January 2020, Eli Lilly and Company entered an agreement to acquire Dermira, a biopharmaceutical company.

Moreover, the presence of major market players and advanced technologies for product development is expected to mark this region as the one with the most dominating share. Additionally, an increase in research and development activities and the presence of favorable healthcare infrastructure are fueling the growth of the overall regional market to a large extent.

Hollow Fiber Filtration Market Competitor Analysis

The Hollow Fiber Filtration Market is competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some companies currently dominating the market are Repligen Corporation, Sartorius, Danaher Corporation, Asahi Kasei Medical Co. Ltd, Parker Hannifin Corp, Mar cor , Koch Separation solutions, Meissner Filtration Products, Inc, Antylia Scientific, and Biotree.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing investment in the Research and development of Biopharmaceuticals
    • 4.2.2 Increasing preference for continous manufacturing
  • 4.3 Market Restraints
    • 4.3.1 Strict government regulations related to drug safety
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Material
    • 5.1.1 Polymer
    • 5.1.2 Ceramic
  • 5.2 By Technique
    • 5.2.1 Microfiltration
    • 5.2.2 Ultrafiltration
  • 5.3 By End user
    • 5.3.1 Pharmaceutical and Biotechnology Industries
    • 5.3.2 Research Organizations
    • 5.3.3 Contract Research Organization
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Repligen Corporation
    • 6.1.2 Sartorius
    • 6.1.3 Danaher Corporation
    • 6.1.4 Asahi Kasei Medical Co., Ltd
    • 6.1.5 Parker Hannifin Corp
    • 6.1.6 Mar cor
    • 6.1.7 Koch Seperation solutions
    • 6.1.8 Meissner Filtration Products, Inc
    • 6.1.9 Antylia Scientific
    • 6.1.10 Biotree

7 MARKET OPPORTUNITIES AND FUTURE TRENDS